Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [857]

Current state of cancer genomics in Africa

Dr Wijden Mahfoudh - Faculty of Medicine of Tunis, Tunis, Tunisia

Current state of cancer genomics in Africa ( Dr Wijden Mahfoudh - Faculty of Medicine of Tunis, Tunis, Tunisia )

Exploring genetic essentiality and drug sensitivity in triple-negative breast...

Dr Ricardo Pinto - i3S, Porto, Portugal

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer ( Dr Ricardo Pinto - i3S, Porto, Portugal )

Improving African representation in breast cancer genomics

Dr Ricardo Pinto - i3S, Porto, Portugal

Improving African representation in breast cancer genomics ( Dr Ricardo Pinto - i3S, Porto, Portugal )

Integrating oncogenetics testing into African clinics and cancer control...

Prof Prisca Adejumo - University of Ibadan, Ibadan, Nigeria

Integrating oncogenetics testing into African clinics and cancer control programs ( Prof Prisca Adejumo - University of Ibadan, Ibadan, Nigeria )

African Oncogenetics Network: improving training and infrastructure in low...

Dr Achille Manirakiza - King Faisal Hospital, Kigali, Rwanda

African Oncogenetics Network: improving training and infrastructure in low-resource regions ( Dr Achille Manirakiza - King Faisal Hospital, Kigali, Rwanda )

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network

Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network ( Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA )

The aims of the African Oncogenetics Network

Dr Yosr Hamdi - Pasteur Institute of Tunis, Tunis, Tunisia

The aims of the African Oncogenetics Network ( Dr Yosr Hamdi - Pasteur Institute of Tunis, Tunis, Tunisia )

MRD validated as a surrogate endpoint for survival in AML

Dr Jesse Tettero - The Hourigan Lab, Washington, D.C., USA

MRD validated as a surrogate endpoint for survival in AML ( Dr Jesse Tettero - The Hourigan Lab, Washington, D.C., USA )

IP6K1-driven tumour polyphosphate may contribute to immune checkpoint inhibitor...

Dr Keith McCrae - Cleveland Clinic, Cleveland, USA

IP6K1-driven tumour polyphosphate may contribute to immune checkpoint inhibitor-associated thrombosis ( Dr Keith McCrae - Cleveland Clinic, Cleveland, USA )

Exploring genomic insights in acute lymphoblastic leukaemia treatment

Prof Charles Mullighan - St. Jude Children's Research Hospital, Memphis, USA

Exploring genomic insights in acute lymphoblastic leukaemia treatment ( Prof Charles Mullighan - St. Jude Children's Research Hospital, Memphis, USA )

AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting...

Dr Roberto Salgado - Peter MacCallum Cancer Centre, Melbourne, Australia

AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab ( Dr Roberto Salgado - Peter MacCallum Cancer Centre, Melbourne, Australia )

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights...

Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights blinatumomab benefits in key high-risk molecular types ( Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA )

More from ecancer